Top Markets
Coin of the day
Rapid Therapeutic Science Laboratories, Inc. Rapid Therapeutic Science Laboratories, Inc.

Rapid Therapeutic Science Laboratories, Inc.

RTSL
Rank in Stocks #42555
Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a biotechnology firm... Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a biotechnology firm specializing in the aerosolized delivery of non-psychoactive cannabinoids directly into the bloodstream. This innovative approach is aimed at treating various conditions, including chronic pain, post-traumatic stress disorder (PTSD), insomnia, and aiding in surgery recovery, among other health issues. RTSL's product portfolio features pressurized meter dose inhalers (MDIs), designed to precisely dispense an aerosolized mist into the lungs, alongside sublingual oral spray devices. Furthermore, the company offers water-soluble cannabidiol (CBD) and cannabigerol (CBG) isolates under its "nhaler" brand. Established in 2013 and based in Dallas, Texas, the company adopted its current name, Rapid Therapeutic Science Laboratories, Inc., in January 2020, having previously operated as Holly Brothers Pictures, Inc. It was also formerly a subsidiary of Texas Mdi, Inc.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$883.00
Change (1 day)
0.00%
Change (1 year)
-96.67%
Country
US
Trade Rapid Therapeutic Science Laboratories, Inc. (RTSL)

Category

Stock price history for Rapid Therapeutic Science Laboratories, Inc. (RTSL)
Highest end of day price: $0.00 on 2026-08-01

Lowest end of day price: $0.85 on 2017-06-01
Stock price history of Rapid Therapeutic Science Laboratories, Inc. from 2017 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.00%
2025 55.30%
2024 -75.53%
2023 -99.59%
2022 324.45%
2021 -65.46%
2020 157.83%
2019 -20.48%
2018 -32.78%
2017 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$110.79 -15.44%
US
$347.16 -7.82%
US
$90.64 -1.57%
IE
$51.40 -49.92%
US
$92.95 20.82%
US